Prostate cancer screening with prostate-specific antigen: Where are we going?
Author:
Affiliation:
1. Department of Surgery (Urology); University of Connecticut Health Center; Farmington Connecticut
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31140/fullpdf
Reference16 articles.
1. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;N Engl J Med.,1987
2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med.,1991
3. Cancer statistics, 2017;Siegel;CA Cancer J Clin.,2017
4. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤ 4.0 ng per milliliter;Thompson;N Engl J Med.,2004
5. A decision analysis of alternative treatment strategies for clinically localized prostate cancer;Fleming;JAMA.,1993
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study;Journal of Clinical Medicine;2023-01-01
2. Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China;Asian Journal of Andrology;2022
3. Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer;Biomedicines;2021-09-15
4. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer;Journal of Experimental & Clinical Cancer Research;2021-04-30
5. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein;PLOS ONE;2021-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3